Catalyst Capital Advisors’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-41,506
Closed -$432K 508
2016
Q1
$432K Sell
41,506
-112,418
-73% -$1.03M 0.07% 202
2015
Q4
$1.55M Sell
153,924
-151,000
-50% -$1.51M 0.22% 101
2015
Q3
$2.56M Sell
304,924
-522,500
-63% -$6.92M 0.34% 87
2015
Q2
$13.3M Sell
827,424
-161,500
-16% -$2.51M 1.55% 7
2015
Q1
$14M Buy
988,924
+300,000
+44% +$3.9M 1.61% 10
2014
Q4
$6.88M Sell
688,924
-35,000
-5% -$300K 0.81% 33
2014
Q3
$6.16M Buy
723,924
+155,000
+27% +$1.36M 0.79% 35
2014
Q2
$5.03M Buy
568,924
+125,748
+28% +$1.1M 0.82% 37
2014
Q1
$4.13M Buy
443,176
+349,000
+371% +$3.06M 0.94% 15
2013
Q4
$795K Buy
94,176
+18,975
+25% +$192K 0.26% 130
2013
Q3
$663K Buy
75,201
+13,516
+22% +$108K 0.36% 117
2013
Q2
$438K Buy
+61,685
New +$426K 0.34% 124

Other funds holding OPK

Catalyst Capital Advisors's OPK Position: Q2 2016 in Review

Catalyst Capital Advisors sold out of Opko Health (OPK) in Q2 2016, closing a stake of 41,506 shares — an estimated $432K sold.

Catalyst Capital Advisors first reported a position in OPK in Q2 2013 and held it in 12 quarters. The position peaked at $14M in Q1 2015. 245 funds tracked by Wall St. Rank hold OPK as of Q2 2016.

  • Catalyst Capital Advisors reported no remaining Opko Health position as of Q2 2016 after selling out during the quarter.
  • Catalyst Capital Advisors sold 41,506 Opko Health shares in Q2 2016, an estimated $432K.
  • Catalyst Capital Advisors first reported a position in Opko Health in Q2 2013 and held it in 12 quarters.
  • Catalyst Capital Advisors's Opko Health position peaked at $14M in Q1 2015.
  • 245 funds tracked by Wall St. Rank held Opko Health as of Q2 2016.

Based on Catalyst Capital Advisors's 13F filing for Q2 2016, filed 10 Aug 2016.